These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30150459)

  • 1. Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis.
    Miller WR; Singh KV; Arias CA; Murray BE
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis.
    Singh KV; Tran TT; Nannini EC; Tam VH; Arias CA; Murray BE
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue.
    Nannini EC; Singh KV; Murray BE
    Clin Infect Dis; 2003 Nov; 37(9):1194-8. PubMed ID: 14557964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of a cefazolin inoculum effect associated with blaZ gene types, and clinical outcomes among methicillin-susceptible Staphylococcus aureus blood isolates of patients with infective endocarditis.
    Bourreau A; Le Mabecque V; Broquet A; Caillon J
    Infect Dis Now; 2023 Feb; 53(1):104626. PubMed ID: 36184048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Insights into the Classification of Staphylococcal β-Lactamases in Relation to the Cefazolin Inoculum Effect.
    Carvajal LP; Rincon S; Echeverri AM; Porras J; Rios R; Ordoñez KM; Seas C; Gomez-Villegas SI; Diaz L; Arias CA; Reyes J
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
    Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
    Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome.
    Chong YP; Park SJ; Kim ES; Bang KM; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):349-55. PubMed ID: 25213722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Test for the Rapid Detection of the Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus.
    Rincon S; Carvajal LP; Gomez-Villegas SI; Echeverri AM; Rios R; Dinh A; Pedroza C; Ordoñez KM; Nannini E; Sun Z; Fowler VG; Murray BE; Miller WR; Palzkill T; Diaz L; Arias CA; Reyes J
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33536292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children.
    McNeil JC; Sommer LM; Boyle M; Hogan P; Vallejo JG; Hultén KG; Flores AR; Kaplan SL; Fritz S
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure.
    Nannini EC; Stryjewski ME; Singh KV; Bourgogne A; Rude TH; Corey GR; Fowler VG; Murray BE
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3437-41. PubMed ID: 19487449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus clinical isolates.
    Tsuji S; Gotoh K; Manabe T; Iio K; Fukushima S; Matsushita O; Hagiya H
    Diagn Microbiol Infect Dis; 2024 Sep; 110(1):116399. PubMed ID: 38875894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefazolin versus cloxacillin in methicillin-susceptible Staphylococcus aureus endocarditis: Too good to be true? Authors' reply.
    Herrera-Hidalgo L; de Alarcón A
    Int J Infect Dis; 2024 May; 142():106979. PubMed ID: 38401779
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus.
    Livorsi DJ; Crispell E; Satola SW; Burd EM; Jerris R; Wang YF; Farley MM
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4474-7. PubMed ID: 22585225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats.
    Catherall EJ; Gillon V; Hurn S; Irwin R; Mizen L
    Antimicrob Agents Chemother; 1992 Feb; 36(2):458-62. PubMed ID: 1605610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inoculum effect of high concentrations of methicillin-susceptible Staphylococcus aureus on the efficacy of cefazolin and other beta-lactams.
    Saeki M; Shinagawa M; Yakuwa Y; Nirasawa S; Sato Y; Yanagihara N; Takahashi S
    J Infect Chemother; 2018 Mar; 24(3):212-215. PubMed ID: 29198902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals.
    Rincón S; Reyes J; Carvajal LP; Rojas N; Cortés F; Panesso D; Guzmán M; Zurita J; Adachi JA; Murray BE; Nannini EC; Arias CA
    J Antimicrob Chemother; 2013 Dec; 68(12):2773-8. PubMed ID: 23794599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Characterization of the Cefazolin Inoculum Effect in North American Methicillin-Susceptible Staphylococcus aureus Isolates.
    Dingle TC; Gamage D; Gomez-Villegas S; Hanson BM; Reyes J; Abbott A; Burnham CD; Dien Bard J; Fritz S; Miller WR; Westblade LF; Zimmer B; Arias CA; Butler-Wu S;
    J Clin Microbiol; 2022 Jul; 60(7):e0249521. PubMed ID: 35578988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
    de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
    Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post-hoc analysis multicentre French cohort study'-author's reply.
    Lecomte R; Deschanvres C; Coudol S; Wargny M; Camou F; Boutoille D
    Clin Microbiol Infect; 2021 Aug; 27(8):1180-1181. PubMed ID: 33813113
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: 'Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post-hoc analysis multicentre French cohort study' by Lecomte et al.
    Buis DTP
    Clin Microbiol Infect; 2021 Aug; 27(8):1179. PubMed ID: 33581355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.